Geoff Levitt is co-chair of DLA Piper’s Life Sciences Policy and Regulatory group. He advises clients on a wide range of regulatory, policy and legislative issues impacting the healthcare and life sciences sectors. 

Geoff previously served as senior vice president and chief counsel for Pfizer Inc.’s Upjohn division in China, as chief regulatory counsel for Pfizer Inc. and Wyeth Pharmaceuticals, and as head of international affairs and policy for Viatris Inc. At Pfizer, he was responsible for managing global legal support for regulatory, medical, safety, clinical research, manufacturing and environmental operations. 

Geoff has published and lectured extensively on regulatory law. He is a past member of the editorial board of the Food and Drug Law Journal and past Chairman of the Board of the Food and Drug Law Institute. He has also served as Chair of the PhRMA Law Section Executive Committee.